106 related articles for article (PubMed ID: 9804761)
1. Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasin.
Mao SS; Przysiecki CT; Krueger JA; Cooper CM; Lewis SD; Joyce J; Lellis C; Garsky VM; Sardana M; Shafer JA
J Biol Chem; 1998 Nov; 273(46):30086-91. PubMed ID: 9804761
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition.
Dunwiddie CT; Smith DE; Nutt EM; Vlasuk GP
Thromb Res; 1991 Dec; 64(6):787-94. PubMed ID: 1798970
[No Abstract] [Full Text] [Related]
3. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site.
Dunwiddie C; Thornberry NA; Bull HG; Sardana M; Friedman PA; Jacobs JW; Simpson E
J Biol Chem; 1989 Oct; 264(28):16694-9. PubMed ID: 2777803
[TBL] [Abstract][Full Text] [Related]
4. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro.
Hauptmann J; Kaiser B
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):577-82. PubMed ID: 8218854
[TBL] [Abstract][Full Text] [Related]
6. Interaction of antistasin-related peptides with factor Xa: identification of a core inhibitory sequence.
Ohta N; Brush M; Jacobs JW
Thromb Haemost; 1994 Dec; 72(6):825-30. PubMed ID: 7740449
[TBL] [Abstract][Full Text] [Related]
7. X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.
Lapatto R; Krengel U; Schreuder HA; Arkema A; de Boer B; Kalk KH; Hol WG; Grootenhuis PD; Mulders JW; Dijkema R; Theunissen HJ; Dijkstra BW
EMBO J; 1997 Sep; 16(17):5151-61. PubMed ID: 9311976
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS).
Danalev DL; Vezenkov LT; Grigorova B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4217-20. PubMed ID: 16084083
[TBL] [Abstract][Full Text] [Related]
9. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.
Franssen J; Salemink I; Willems GM; Wun TC; Hemker HC; Lindhout T
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):33-7. PubMed ID: 9173898
[TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site.
Hofmann KJ; Nutt EM; Dunwiddie CT
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):943-9. PubMed ID: 1445252
[TBL] [Abstract][Full Text] [Related]
11. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS).
Hauptmann J; Kaiser B
Thromb Res; 1993 Jul; 71(2):169-74. PubMed ID: 8362380
[No Abstract] [Full Text] [Related]
13. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa.
Nutt EM; Jain D; Lenny AB; Schaffer L; Siegl PK; Dunwiddie CT
Arch Biochem Biophys; 1991 Feb; 285(1):37-44. PubMed ID: 1990979
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae.
Przysiecki CT; Joyce JG; Keller PM; Markus HZ; Carty CE; Hagopian A; Sardana MK; Dunwiddie CT; Ellis RW; Miller WJ
Protein Expr Purif; 1992 Jun; 3(3):185-95. PubMed ID: 1392615
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of the N-terminal half of antistasin, an anticoagulant protein derived from the leech Haementeria officinalis.
Palladino LO; Tung JS; Dunwiddie C; Alves K; Lenny AB; Przysiecki C; Lehman D; Nutt E; Cuca GC; Law SW
Protein Expr Purif; 1991 Feb; 2(1):37-42. PubMed ID: 1821771
[TBL] [Abstract][Full Text] [Related]
16. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
Mesters RM; Heeb MJ; Griffin JH
Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
[TBL] [Abstract][Full Text] [Related]
17. The hydrolysis and resynthesis of a single reactive site peptide bond in recombinant antistasin by coagulation factor Xa.
Dunwiddie CT; Vlasuk GP; Nutt EM
Arch Biochem Biophys; 1992 May; 294(2):647-53. PubMed ID: 1567219
[TBL] [Abstract][Full Text] [Related]
18. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
Stevic I; Berry LR; Chan AK
J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.
Deguchi H; Takeya H; Gabazza EC; Nishioka J; Suzuki K
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):729-35. PubMed ID: 9032460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
